Anthropic is operating a lab that conducts biology experiments

Anthropic has confirmed that it has a wet biology lab where it can use its AI models to run physical experiments.

AI leaders have been promising that AI is the key to curing human disease. Dario Amodei opined just last week: “I believe that AI could cure most major diseases in the next 5–10 years.” To do that, an LLM would have to have methods to test its theories in real life.

“We believe that to do biology, the final test is still, and will be for a while, in real lab work,” Anthropic’s head of life sciences, Eric Kauderer-Abrams told Reuters. “We absolutely are doing that today.” He added that the lab operates like most biotech labs: Anthropic conducts some research there while also working with externals partners.

This news probably shouldn’t be shocking. Anthropic bought Coefficient Bio, a stealth AI biotech, in April. It declined to say what the wet lab is working on, except that it’s not focused on drug discovery. Anthropic doesn’t want to give the appearance of competing with the pharma industry, where it has numerous major customers and partners. (For instance, it just announced a deal to work with Novo Nordisk on joint drug discovery.) Anthropic has already faced backlash for launching products perceived to compete with those of its customers.

To that end, Anthropic also launched a Life Sciences Verification Program this week, to give vetted bio researchers access to its most powerful models.

But the world is still reeling from the resignation of Anthropic researcher Jacob Coxon, who warned that “the people building AI earnestly believe that it could kill us all by the end of the decade.” Anthropic’s own alignment lead gave the odds at greater than 10% that AI could exterminate humanity within the next decade.

The fervor has grown so intense that CEO Dario Amodei published a post last weekend calling on the industry to slow down and institute self-regulation. He has repeatedly called bioterrorism one of AI’s biggest risks.